Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_assertion type Assertion NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_head.
- NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_assertion wasGeneratedBy ECO_0000203 NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_provenance.
- NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_assertion wasDerivedFrom befree-20150227 NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_provenance.
- NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_assertion SIO_000772 17659339 NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_provenance.
- NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_assertion evidence source_evidence_literature NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_provenance.
- NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_assertion description "[The discovery of apoptotic pathways that can be manipulated by proteasome inhibition provides rationale for the combination of bortezomib and agents such as TRAIL in CHL treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804328.RAA3on4-Bv2i8Tl24bJd9WQ1M-laVqj6vTBSvd5OHcrXE130_provenance.